Orange Book product · Generic (ANDA)
LANSOPRAZOLE
LANSOPRAZOLE
At a glance
Nov 04, 2024
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 04, 2024
1 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
LANSOPRAZOLE
Strength
15MG
Dosage form
CAPSULE, DELAYED REL PELLETS
Route
ORAL
TE code
Not listed
Application
ANDA 208671
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LANSOPRAZOLE
- 2016LANSOPRAZOLEBrand (NDA)
NDA 208025 · DEXCEL
- 2009PREVACID 24 HRBrand (NDA)
NDA 022327 · PERRIGO PHARMA INTL
- 2004PREVACID IVBrand (NDA)
NDA 021566 · TAKEDA PHARMS NA
- 2002PREVACIDBrand (NDA)
NDA 021428 · TAKEDA PHARMS USA
- 2001PREVACIDBrand (NDA)
NDA 021281 · TAKEDA PHARMS NA
- 1995PREVACIDBrand (NDA)
NDA 020406 · TAKEDA PHARMS USA
- 2023LANSOPRAZOLEGeneric (ANDA)
ANDA 207167 · AUROBINDO PHARMA LTD
- 2021LANSOPRAZOLEGeneric (ANDA)
ANDA 210465 · DR REDDYS
- 2020LANSOPRAZOLEGeneric (ANDA)
ANDA 203083 · HETERO LABS LTD III
- 2019LANSOPRAZOLEGeneric (ANDA)
ANDA 207394 · ALKEM LABS LTD
- 2018LANSOPRAZOLEGeneric (ANDA)
ANDA 202396 · MYLAN
- 2018LANSOPRAZOLEGeneric (ANDA)
ANDA 200816 · ZYDUS PHARMS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
